EDD Inhibitors
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $260.00 $925.00 | 5 | |
C646 is a histone acetyltransferase (HAT) inhibitor that specifically targets p300, a HAT involved in EDD regulation. By inhibiting p300, C646 disrupts acetylation events crucial for EDD activation, thereby modulating its function. | ||||||
SB 202190 | 152121-30-7 | sc-202334 sc-202334A sc-202334B | 1 mg 5 mg 25 mg | $30.00 $125.00 $445.00 | 45 | |
SB202190 acts as a selective inhibitor of p38 MAPK, a pathway associated with EDD signaling. By blocking p38 MAPK activation, SB202190 indirectly influences EDD, disrupting the downstream events involved in its modulation. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $92.00 $223.00 | 30 | |
PP2 is a potent inhibitor of Src family kinases (SFKs), which play a role in EDD-related pathways. Inhibition of SFKs by PP2 disrupts the signaling cascade leading to EDD modulation, affecting its activation and downstream effects. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR, a key regulator in cellular pathways linked to EDD. By disrupting mTOR signaling, Rapamycin indirectly modulates EDD, affecting its activation and downstream cellular responses. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor, influencing the PI3K/Akt pathway associated with EDD. Inhibition of PI3K by LY294002 disrupts the signaling cascades regulating EDD, leading to modulation of its activation and cellular effects. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
JQ1 is a bromodomain and extraterminal (BET) protein inhibitor that indirectly modulates EDD. By inhibiting BET proteins, JQ1 affects the transcriptional events linked to EDD, altering its expression and cellular functions. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 is a MEK1/2 inhibitor targeting the MAPK pathway. By inhibiting MEK1/2, U0126 disrupts the MAPK pathway, influencing EDD indirectly and altering its activation and downstream cellular responses. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor that affects the JNK signaling pathway linked to EDD. Inhibition of JNK by SP600125 modulates EDD indirectly, disrupting the signaling cascades and cellular events involved in its regulation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is a potent PI3K inhibitor that influences the PI3K/Akt pathway associated with EDD. By inhibiting PI3K, Wortmannin disrupts the signaling cascades regulating EDD, leading to modulation of its activation and effects. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 is a selective inhibitor of MEK1, a component of the MAPK pathway. Inhibiting MEK1 with PD98059 disrupts the MAPK pathway, indirectly modulating EDD and altering its activation and downstream cellular responses. | ||||||